Maven Securities’s Neuronetics STIM Stock Holding History

Maven Securities’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,221	Closed	-$27K	–	1315
2021 Q1	$27K	Buy	+2,221	New	+$34K	﹤0.01%	1133

Other funds holding STIM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Maven Securities's STIM Position: Q2 2021 in Review

Maven Securities sold out of Neuronetics (STIM) in Q2 2021, closing a stake of 2,221 shares — an estimated $27K sold.

Maven Securities first reported a position in STIM in Q1 2021 and held it in 1 quarter. The position peaked at $27K in Q1 2021. 105 funds tracked by Wall St. Rank hold STIM as of Q2 2021.

Maven Securities reported no remaining Neuronetics position as of Q2 2021 after selling out during the quarter.
Maven Securities sold 2,221 Neuronetics shares in Q2 2021, an estimated $27K.
Maven Securities first reported a position in Neuronetics in Q1 2021 and held it in 1 quarter.
Maven Securities's Neuronetics position peaked at $27K in Q1 2021.
105 funds tracked by Wall St. Rank held Neuronetics as of Q2 2021.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.